Drug Trial Radar · NCT06542614
Treatment of Moderate to Severe Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Jan 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
209
Actual
Start
Aug 27, 2024
Primary completion
Nov 3, 2025
Study completion Dec 6, 2025
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the efficacy and safety of TQH3906 in subjects with moderate to severe plaque psoriasis, as well as the PK and PD characteristics of multiple doses
Conditions
- Plaque Psoriasis
Interventions
TQH3906 capsulesDrug
To assess the efficacy and safety of TQH3906 in subjects with moderate to severe plaque psoriasis.
Placebo of TQH3906 capsulesDrug
Placebo without drug substance.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients achieving Psoriasis Area and Severity Index (PASI) 75 at week 12Time frame: Up to week 12
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The first affiliated hospital of chongqing medical university
Chongqing, Chongqing Municipality, China
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
Liuzhou People'S Hospital
Liuzhou, Guangxi, China
Shijiazhuang Hospital of Traditional Chinese Medicine
Shijiazhuang, Hebei, China
The Second Hospital of HeBei Medical University
Shijiazhuang, Hebei, China
The Second Affiliated Hospital Of Xingtai Medical Colledge
Xingtai, Hebei, China
Heilongjiang Provincial Hospital
Harbin, Heilongjiang, China
The Second Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Nanyang First People'S Hospital
Nanyang, Henan, China
Shiyan Renmin Hospital
Shiyan, Hubei, China
Wuhan First Hospital
Wuhan, Hubei, China
The First People's Hospital of Changde
Changde, Hunan, China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
The First Affiliated Hospital of Baotou Medical College
Baotou, Inner Mongolia, China
Hospital of Dermatology, Chinese Academy of Medical Sciences
Nanjing, Jiangsu, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Yancheng First People's Hospital
Yancheng, Jiangsu, China
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
Meihekou Central Hospital
Meihekou, Jilin, China
Genertec Liaoyou Gem Flower Hospital
Panjin, Liaoning, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
The first hospital of china medical university
Shenyang, Liaoning, China
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Shandong First Medical University Affiliated Dermatology Hospital
Jinan, Shandong, China
Shandong University Qilu Hospital
Jinan, Shandong, China
Qingdao Municipal hospital (group)
Qingdao, Shandong, China
Qingdao Traditional Chinese Medicine Hospital
Qingdao, Shandong, China
Shanghai JiaoTong University of medicine Ruijin Hospital
Shanghai, Shanghai Municipality, China
Shanxi Provincial People's Hospital
Taiyuan, Shanxi, China
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin Municipality, China
Xinjiang Uygur Autonomous Region People's Hospital
Ürümqi, Xinjiang, China
Affiliated Hangzhou First People'S Hospital,School of Medicine, Westlake University
Hangzhou, Zhejiang, China
The Second Affiliated Hospital Zhejiang University School Of Medicine
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.